Brief: Board Of Directors Decides On Execution Of Rights Issue

Initiator Pharma A/S

01/06/2022 06:13

June 1 (Reuters) - Initiator Pharma A/S  INIT.ST :
    * SAID ON TUESDAY, BOARD OF DIRECTORS DECIDES ON EXECUTION
OF
RIGHTS ISSUE
    * RESOLVED TO CARRY OUT A FULLY SECURED SHARE ISSUE OF
APPROX. SEK
41 MILLION WITH PREFERENTIAL RIGHTS FOR EXISTING SHAREHOLDERS
    * RIGHTS ISSUE IS EXPECTED TO INCREASE INITIATOR'S SHARE
CAPITAL
BY A MAXIMUM OF DKK 573,659.73, FROM CURRENT DKK 4,876,108.44 TO
NO MORE THAN DKK 5,449,768.17
    * SUBSCRIPTION PERIOD: 16-30 JUNE 2022.
    * SUBSCRIPTION PRICE IN RIGHTS ISSUE IS SEK 7.50 PER SHARE,
WHICH
IS SAME PRICE AS IN RECENTLY EXECUTED DIRECTED SHARE ISSUE.
    * FOR EACH EXISTING SHARE, ONE (1) SUBSCRIPTION RIGHT IS
RECEIVED.
    * SEVENTEEN (17) SUBSCRIPTION RIGHTS ENTITLE HOLDER TO
SUBSCRIBE
FOR TWO (2) NEW SHARES

Source text for Eikon:  ID:nMFNNKK78 
Further company coverage:  INIT.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))